Aerpio Therapeutics, Inc. — Form D

Aerpio Therapeutics, Inc. of CINCINNATI, OH, a company, filed a Form D exempt-offering notice with the SEC on 2016-11-14. The offering totals $4.6M, of which $3.5M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (25)

NameRoleLocation
Reinhard H AmbrosDirectorCincinnati, OH
Anupam H DalalDirectorCincinnati, OH
Joseph H GardnerDirectorCincinnati, OH
Adrienne H GravesDirectorCincinnati, OH
Chau H KhuongDirectorCincinnati, OH
Campbell H MurrayDirectorCincinnati, OH
Duane H NashDirectorCincinnati, OH
John H RiceDirectorBethesda, MD
Muneer H SatterDirectorCincinnati, OH
Paul H WeissDirectorCincinnati, OH
Joseph H GardnerExecutive OfficerCincinnati, OH
Steve H PakolaExecutive OfficerCincinnati, OH
Kevin H PetersExecutive OfficerCincinnati, OH
Ian AW HowesExecutive OfficerSeattle, WA
Lauren H SilvermanDirectorCincinnati, OH
Robert H ShalwitzExecutive OfficerCincinnati, OH
William H DalyExecutive OfficerCincinnati, OH
Alan H FishmanExecutive OfficerCincinnati, OH
Kevin AW PetersExecutive OfficerCincinnati, OH
Adrienne AW GravesDirectorCincinnati, OH
Campbell AW MurrayDirectorCincinnati, OH
John AW RiceDirectorCincinnati, OH
Robert AW ShalwitzExecutive OfficerCincinnati, OH
Anupam AW DalalDirectorCincinnati, OH
Paul AW WeissDirectorCincinnati, OH

Other filings by this issuer (6)

FiledFormOfferingSold
2016-04-15D$9.2M$4.5M
2014-05-06D$22.0M$22.0M
2013-11-15D/A$31.0M$27.0M
2013-09-12D/A$21.9M$18.0M
2012-11-16D$21.9M$10.0M
2012-01-05D$5.0M$5.0M

More